




Leaders in Research
You may view the list of scholars arranged
Arti Hurria, MD Assistant Professor and Director, Cancer & Aging Research Program Division of Medical Oncology & Therapeutics Research
City of Hope Comprehensive Cancer Center
The overarching goal of Dr. Hurria’s research is to develop a geriatric instrument for older patients with cancer that improves the oncologist’s ability to: 1) anticipate chemotherapy toxicity, 2) predict overall outcomes, and 3) develop interventions to improve outcomes in the older cancer patient. Existing oncology instruments are largely inapplicable to the older adult because they were validated in younger patients and do not address the critical domains of geriatric assessment that predict morbidity and mortality in the older patient.
This research program, developed with the mentorship of Dr. George Bosl (oncologist) and Dr. Mark Lachs (geriatrician), proposes to integrate recent advances in geriatric assessment, clinical epidemiology, and psychometrics to create a clinically useful tool for the practicing oncologist. We hypothesize that a cancer-specific geriatric instrument can be formulated to identify factors independent of age that predict cancer treatment morbidity and mortality and result in rationale interventions to optimize oncologic care.
Dr. Hurria currently holds a faculty position at Memorial Sloan-Kettering Cancer Center, where she has spent the last three years immersed in clinical care and research focused on geriatric oncology patients with breast cancer. She received her MD from Northwestern Medical School. Following a residency at Beth Israel Medical Center, she completed a fellowship at Harvard Geriatrics Fellowship and a fellowship in oncology/hematology at Memorial Sloan-Kettering Cancer Center.
|
| |
Primary Research (for Beeson Program): Can Geriatric Assessment Predict Oncology Outcomes?
|